Yoko Pharma
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Yoko Pharma - overview
Established
2002
Location
Nanjing, Jiangsu, China
Primary Industry
Biotechnology
About
Based in Nanjing, China and established in 2002, Yoko Pharma is a bio-pharmaceutical company that focuses on the development, manufacture and marketing of injection drugs.
Current Investors
IDG Capital, LYFE Capital, CreditEase Wealth Management
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.yoko-bio.com
Company Stage
Series C
Total Amount Raised
Subscriber access only
Yoko Pharma - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series C | Completed | Yoko Pharma | - | ||||||||
| Series B | Completed | Yoko Pharma | - | ||||||||
| Series A | Completed | Yoko Pharma | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.